title: Association of angiotensin-converting enzyme activity and polymorphism with echocardiographic measures in familial and nonfamilial hypertrophic cardiomyopathy.
abstract: Angiotensin-converting enzyme (ACE) activity and polymorphism contribute significantly to the prognosis of patients with cardiomyopathy. The aim of this study was to determine the activity and type of ACE polymorphism in patients with familial and nonfamilial hypertrophic cardiomyopathy (HCM) and to correlate these with echocardiographic measurements (echo-Doppler). We studied 136 patients (76 males) with HCM (69 familial and 67 nonfamilial cases). Mean age was 41 +/- 17 years. DNA was extracted from blood samples for the polymerase chain reaction and the determination of plasma ACE levels. Left ventricular mass, interventricular septum, and wall thickness were measured. Mean left ventricular mass index, interventricular septum and wall thickness in familial and nonfamilial forms were 154 +/- 63 and 174 +/- 57 g/m(2) (P = 0.008), 19 +/- 5 and 21 +/- 5 mm (P = 0.02), and 10 +/- 2 and 12 +/- 3 mm (P = 0.0001), respectively. ACE genotype frequencies were DD = 35%, ID = 52%, and II = 13%. A positive association was observed between serum ACE activity and left ventricular mass index (P = 0.04). Logistic regression showed that ACE activity was twice as high in patients with familial HCM and left ventricular mass index >or=190 g/m(2) compared with the nonfamilial form (P = 0.02). No other correlation was observed between ACE polymorphisms and the degree of myocardial hypertrophy. In conclusion, ACE activity, but not ACE polymorphisms, was associated with the degree of myocardial hypertrophy in the patients with HCM.
authors.affiliation: Unidade Clínica de Miocardiopatias, Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil. paula.buck@incor.usp.br
authors.forename: P C
authors.initials: PC
authors.lastname: Buck
authors.forename: F
authors.initials: F
authors.lastname: Fernandes
authors.forename: E
authors.initials: E
authors.lastname: Arteaga
authors.forename: A Y
authors.initials: AY
authors.lastname: Matsumoto
authors.forename: A Q
authors.initials: AQ
authors.lastname: Araujo
authors.forename: E M
authors.initials: EM
authors.lastname: Oliveira
authors.forename: B M
authors.initials: BM
authors.lastname: Ianni
authors.forename: F J A
authors.initials: FJ
authors.lastname: Ramires
authors.forename: J E
authors.initials: JE
authors.lastname: Krieger
authors.forename: C
authors.initials: C
authors.lastname: Mady
mesh_terms: D000328:Adult; D002312:Cardiomyopathy, Hypertrophic / Q000000981:diagnostic imaging / Q000201:enzymology* / Q000235:genetics; D024741:Cardiomyopathy, Hypertrophic, Familial / Q000000981:diagnostic imaging / Q000201:enzymology / Q000235:genetics; D015150:Echocardiography, Doppler; D005260:Female; D005838:Genotype; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000235:genetics* / Q000378:metabolism*; D010641:Phenotype; D011110:Polymorphism, Genetic / Q000235:genetics*; D012720:Severity of Illness Index
chemical_list: D007703:Peptidyl-Dipeptidase A